For every $28,000 the federal government spends on care for Alzheimer’s disease patients, it only spends $100 on Alzheimer’s disease research.
Current Efficacy Trials Often Produce Ineffective Treatments and Prevent Access to Effective Ones
Modern drug efficacy trials are unnecessarily small, expensive, slow, and unrepresentative of true effectiveness in real-world patients.
Clinical Trial Exclusion Criteria
Subjects in FDA Trials Are Not Representative of the Actual People Receiving Treatment External validity is the extent to which the results can be generalized to a population of interest. The population of interest is usually defined as the people the intervention is intended to help. Phase III clinical trials are designed to exclude a […]
Has Celiac Disease Been Increasing?
Between 1990 and 2010, the incidence of celiac disease quadrupled in the United Kingdom.